1-3 of 3
Kasia Kozlowski
Close
Sort by
Journal Articles

Poor adherence is the main reason for loss of CCyR and imatinib failure for chronic myeloid leukemia patients on long-term therapy

Brief Report
Amr R. Ibrahim, Lina Eliasson, Jane F. Apperley, Dragana Milojkovic, Marco Bua, Richard Szydlo, Francois-Xavier Mahon, Kasia Kozlowski, Christos Paliompeis, Letizia Foroni, Jamshid S. Khorashad, Alex Bazeos, Mathieu Molimard, Alistair Reid, Katayoun Rezvani, Gareth Gerrard, John Goldman, David Marin
Journal: Blood
Blood (2011) 117 (14): 3733–3736.
https://doi.org/10.1182/blood-2010-10-309807
Published: 2011
Journal Articles

Long Term Adherence to Imatinib Therapy Is the Critical Factor for Achieving Molecular Responses in Chronic Myeloid Leukemia Patients.

Alex Bazeos, Jamshid Khorashad, François-Xavier Mahon, Lina L Eliasson, Dragana Milojkovic, Marco Bua, Jane Apperley, Richard Szydlo, Kasia Kozlowski, Christos Paliompeis, Ritti Desai, Letizia Foroni, Alistair Reid, Hugues de Lavallade, Katy Rezvani, John Goldman, David Marin
Journal: Blood
Blood (2009) 114 (22): 3290.
https://doi.org/10.1182/blood.V114.22.3290.3290
Published: 2009
Journal Articles

Prediction of Cytogenetic Response to Second Generation TKI Therapy in CML Chronic Phase Patients Who Have Failed Imatinib Therapy and Early Identification of Factors That Influence Survival

Dragana Milojkovic, Marco Bua, Jane F Apperley, Kasia Kozlowski, Jamshid Sorori, Letizia Foroni, Alistair Reid, Jiri Pavlu, Katy Rezvani, Francesco Dazzi, Eduardo Olavarria, Matthias Klammer, John M Goldman, David Marin
Journal: Blood
Blood (2008) 112 (11): 332.
https://doi.org/10.1182/blood.V112.11.332.332
Published: 2008